We are live on ! Find out more
AAP

Aristotle Atlantic Partners Portfolio holdings

AUM $2.14B
1-Year Est. Return 37.01%
This Fund
S&P 500
This Quarter Est. Return
+14.31%
1 Year Est. Return
+37.01%
3 Year Est. Return
+123.74%
5 Year Est. Return
+154.13%
10 Year Est. Return
AUM
$2.84B
AUM Growth
+$344M
Cap. Flow
+$14.3M
Cap. Flow %
0.5%
Top 10 Hldgs %
43.4%
Holding
102
New
4
Increased
47
Reduced
20
Closed
6

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$21.9M
2
PEP icon
PepsiCo
PEP
+$17.7M
3
BMY icon
Bristol-Myers Squibb
BMY
+$13.1M
4
UNH icon
UnitedHealth
UNH
+$10.6M
5
QQQ icon
Invesco QQQ Trust
QQQ
+$10.2M

Sector Composition

Rank Sector Weight
1 Technology 35.49%
2 Healthcare 15.73%
3 Consumer Discretionary 11.21%
4 Financials 10.16%
5 Communication Services 8.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BDX icon
26
Becton Dickinson
BDX
$43.1B
$31.2M 1.1%
128,055
+35
+0% +$8.63K
ACN icon
27
Accenture
ACN
$89.9B
$30.3M 1.07%
86,480
+13
+0% +$4.19K
ICE icon
28
Intercontinental Exchange
ICE
$82.4B
$29.4M 1.03%
228,895
+558
+0.2% +$63.3K
ORLY icon
29
O'Reilly Automotive
ORLY
$72.4B
$28.3M 1%
447,315
+6,435
+1% +$407K
KLAC icon
30
KLA
KLAC
$275B
$27.5M 0.97%
472,520
+5,990
+1% +$312K
UNH icon
31
UnitedHealth
UNH
$382B
$27.4M 0.96%
52,021
-19,835
-28% -$10.6M
CB icon
32
Chubb
CB
$140B
$27.2M 0.96%
120,171
-15,701
-12% -$3.43M
CI icon
33
Cigna
CI
$76.6B
$27M 0.95%
90,186
-19,870
-18% -$5.81M
ROP icon
34
Roper Technologies
ROP
$36.3B
$26.9M 0.95%
49,380
+2,930
+6% +$1.51M
MAR icon
35
Marriott International
MAR
$98.7B
$26.5M 0.93%
117,370
+459
+0.4% +$93.1K
AMP icon
36
Ameriprise Financial
AMP
$46.8B
$26.3M 0.93%
69,302
+21
+0% +$7.2K
XOM icon
37
ExxonMobil
XOM
$651B
$25.5M 0.9%
255,482
DXCM icon
38
DexCom
DXCM
$27.6B
$25.2M 0.89%
203,154
+2,323
+1% +$237K
AVY icon
39
Avery Dennison
AVY
$12.3B
$24.9M 0.88%
123,170
-55
-0% -$10.3K
IDXX icon
40
Idexx Laboratories
IDXX
$42.9B
$24.1M 0.85%
43,403
+269
+0.6% +$126K
UNP icon
41
Union Pacific
UNP
$183B
$23.2M 0.82%
94,350
ABT icon
42
Abbott
ABT
$180B
$23.1M 0.81%
210,084
-34,423
-14% -$3.44M
GH icon
43
Guardant Health
GH
$19.5B
$22.6M 0.8%
836,945
+2,849
+0.3% +$74.7K
ON icon
44
ON Semiconductor
ON
$33.8B
$22.1M 0.78%
264,612
+79,046
+43% +$6.21M
TFX icon
45
Teleflex
TFX
$5.85B
$21.3M 0.75%
85,478
-94
-0.1% -$20.1K
GTLS
46
DELISTED
Chart Industries
GTLS
$21M 0.74%
153,820
+6,159
+4% +$832K
ZTS icon
47
Zoetis
ZTS
$31.6B
$20.3M 0.71%
102,868
+26,430
+35% +$4.68M
GOOG icon
48
Alphabet (Google) Class C
GOOG
$3.9T
$19.4M 0.68%
137,317
+20
+0% +$2.71K
NEE icon
49
NextEra Energy
NEE
$187B
$19.3M 0.68%
318,101
+780
+0.2% +$44.5K
AMAT icon
50
Applied Materials
AMAT
$426B
$18.4M 0.65%
113,340
+591
+0.5% +$86.8K

Similar funds

Aristotle Atlantic Partners's Q4 2023 Portfolio in Review

As of Q4 2023, Aristotle Atlantic Partners held 102 positions worth $2.84B, up 14% from $2.5B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Aristotle Atlantic Partners's Q4 2023 filing shows 4 new, 47 increased, 20 reduced and 6 closed positions. Its largest new stake was Datadog: 11,972 shares worth $1.45M. The largest sale was Tesla, an estimated $21.9M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 34% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Aristotle Atlantic Partners's largest Q4 2023 buy was Datadog: 11,972 shares worth $1.45M.
  • Aristotle Atlantic Partners added most to Meta Platforms (Facebook) in Q4 2023, an estimated $22.3M increase.
  • Aristotle Atlantic Partners's biggest Q4 2023 reduction was Tesla, cutting an estimated $21.9M.
  • Aristotle Atlantic Partners fully exited PepsiCo in Q4 2023, selling an estimated $17.7M.
  • Aristotle Atlantic Partners's ten largest holdings make up 43% of its $2.84B portfolio in Q4 2023.
  • Aristotle Atlantic Partners opened 4 new positions and closed 6 in Q4 2023.
  • Aristotle Atlantic Partners's portfolio value rose 14% quarter-over-quarter to $2.84B.

Based on Aristotle Atlantic Partners's 13F filing for Q4 2023, filed 14 Feb 2024.